[HTML][HTML] Milk antibody response after 3rd COVID-19 vaccine and SARS-CoV-2 infection and implications for infant protection

Y Golan, M Ilala, L Li, C Gay, S Hunagund, CY Lin… - Iscience, 2023 - cell.com
Little is known about the persistence of human milk anti-SARS-CoV-2 antibodies after 2 nd
and 3 rd vaccine doses and infection following 3 rd dose. In this study, human milk, saliva …

[HTML][HTML] Deciphering the neurosensory olfactory pathway and associated neo-immunometabolic vulnerabilities implicated in COVID-associated mucormycosis (CAM) …

M Sharma, HP Vanam, NK Panda, SK Patro, R Arora… - Diabetology, 2022 - mdpi.com
Recent Mucorales-mediated outbreaks of infections and an association of fungal infection
with COVID-19 cases, as observed for COVID-19-associated mucormycosis (CAM), have …

Enhancing pulmonary delivery and immunomodulation of respiratory diseases through virus-mimicking nanoparticles

YA Martins, IC Guerra-Gomes, TS Rodrigues… - Journal of Controlled …, 2024 - Elsevier
This study introduces the nanobromhexine lipid particle (NBL) platform designed for
effective pulmonary drug delivery. Inspired by respiratory virus transport mechanisms, NBL …